Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
Richard Nellis van Zyl-SmitKenneth R ChapmanHuib A M KerstjensChristian GessnerHironori SagaraAna-Maria TanaseMotoi HosoeAbhijit PetheDavid LawrenceHanns-Christian TillmannPeter D'AndreaPublished in: Journal of asthma and allergy (2023)
These formulations therefore provide novel once-daily treatment options for patients across asthma severity and flexibility for clinicians to step-up or step-down the treatment using the same device and formulations.